Acute and subacute effects of haloperidol on dopac levels in the substantia nigra and ventral tegmental area of rat brain.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism*; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D004334:Drug Administration Schedule; D006220:Haloperidol / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D010648:Phenylacetates / Q000378:metabolism*; D051381:Rats; D013378:Substantia Nigra / Q000378:metabolism*; D013681:Tegmentum Mesencephali / Q000378:metabolism*
D010648:Phenylacetates; D015102:3,4-Dihydroxyphenylacetic Acid; D006220:Haloperidol